Details for New Drug Application (NDA): 085020
✉ Email this page to a colleague
NDA 085020 describes DEAPRIL-ST, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. Additional details are available on the DEAPRIL-ST profile page.
The generic ingredient in DEAPRIL-ST is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
The generic ingredient in DEAPRIL-ST is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
Summary for 085020
| Tradename: | DEAPRIL-ST |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | ergoloid mesylates |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085020
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 1MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
